Hereditary Hemorrhagic Telangiectasia clinical trials

Explore recruiting hereditary hemorrhagic telangiectasia clinical trials.

Recruiting hereditary hemorrhagic telangiectasia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hereditary Hemorrhagic Telangiectasia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Mass balance study of [14C]-VAD044

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

InsigHHT: A Phase 1/2, Randomized, Double-blind, Placebo-controlled, 2 part Study of the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Dose ALN-6400 in Adult Healthy Volunteers and Multiple Dose ALN 6400 in Adult Patients with Hereditary Hemorrhagic Telangiectasia (HHT)

France, Spain, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Phase II randomized study on efficacy of nintedanib for treatment of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients - EPISTOP

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Hereditary Hemorrhagic Telangiectasia trials by city

Hereditary Hemorrhagic Telangiectasia in Toronto Hereditary Hemorrhagic Telangiectasia in Vancouver Hereditary Hemorrhagic Telangiectasia in Montreal Hereditary Hemorrhagic Telangiectasia in Calgary Hereditary Hemorrhagic Telangiectasia in Edmonton Hereditary Hemorrhagic Telangiectasia in Ottawa Hereditary Hemorrhagic Telangiectasia in Winnipeg Hereditary Hemorrhagic Telangiectasia in Quebec City Hereditary Hemorrhagic Telangiectasia in Hamilton Hereditary Hemorrhagic Telangiectasia in Kitchener Hereditary Hemorrhagic Telangiectasia in London Hereditary Hemorrhagic Telangiectasia in Halifax Hereditary Hemorrhagic Telangiectasia in New York Hereditary Hemorrhagic Telangiectasia in Los Angeles Hereditary Hemorrhagic Telangiectasia in Chicago Hereditary Hemorrhagic Telangiectasia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease